Live
FierceBiotechcAMPfield harvests $180M series A to advance oral IBD drug licensed from NewsoaraEndpoints NewsIRA's Medicare out-of-pocket cap increased access to drugs, study findsEndpoints NewsPrepping for peptidesBioPharma DivePfizer CFO to step down; Denali sells a regulatory fast-passEndpoints NewsPfizer CFO to depart; GSK wins approval for UTI drugEndpoints NewsRA, Forbion and Sanofi Ventures appear to back new eye drug from KoreaEndpoints NewsNovocure’s electric fields therapy fails key glioblastoma studyBioWorldShanghai Pharmaceuticals discovers new IL-17A inhibitorsBioWorldConvalife presents new dual CDK4/cyclin D1 and CDK9 inhibitorsBioWorldInsilico Medicine synthesizes new Nav1.8 blockersBioWorldSunshine Lake Pharma identifies new GTPase KRAS G12C inhibitorsPharmaVoiceAs M&A rebounds, here’s how pharmas can prepare to seal a deal
Cet article n'est pas disponible dans les archives.